Clinical trial • Phase III • Oncology
Clinical trial in Advanced metastatic pancreatic adenocarcinoma
Phase III trial for Advanced metastatic pancreatic adenocarcinoma. 54 participants.
Overview
- Trial Therapeutic Area
- Oncology
- Trial Disease
- Advanced metastatic pancreatic adenocarcinoma
- Trial Stage
- Phase III
Key dates
- Initial CTIS Submission Date
- 12-06-2025
- First CTIS Authorization Date
- 01-09-2025
Trial design
Phase III trial across 6 sites in Spain.
- Target Sample Size
- 54
- Trial Duration For Participant
- 1398
Recruitment
- Planned Sample Size
- 54
- Recruitment Window Months
- 45
Geography
- Total Number Of Sites
- 6
- Total Number Of Participants
- 54
Spain
- Earliest CTIS Part Ii Submission Date
- 16-07-2025
- Latest Decision Or Authorization Date
- 11-02-2026
- Processing Time Days
- 210
- Number Of Sites
- 6
- Number Of Participants
- 54
Sites
- Site Name
- Hospital Universitario 12 De Octubre
- Department Name
- Oncology
- Principal Investigator Name
- Rocío García Carbonero
- Principal Investigator Email
- rgcarbonero@gmail.com
- Contact Person Name
- Rocío García Carbonero
- Contact Person Email
- rgcarbonero@gmail.com
- Site Name
- Hospital Universitario Donostia
- Department Name
- Oncology
- Principal Investigator Name
- Ander URRUTICOECHEA RIBATE
- Principal Investigator Email
- ANDER.URRUTICOECHEARIBATE@osakidetza.eus
- Contact Person Name
- Ander URRUTICOECHEA RIBATE
- Contact Person Email
- ANDER.URRUTICOECHEARIBATE@osakidetza.eus
- Site Name
- Hospital Universitari Vall D Hebron
- Department Name
- Oncology
- Principal Investigator Name
- Jaume Capdevila
- Principal Investigator Email
- jcapdevila@vhio.net
- Contact Person Name
- Jaume Capdevila
- Contact Person Email
- jcapdevila@vhio.net
- Site Name
- Clinica Universidad De Navarra
- Department Name
- Oncology
- Principal Investigator Name
- Mariano Ponz Sarvisé
- Principal Investigator Email
- mponz@unav.es
- Contact Person Name
- Mariano Ponz Sarvisé
- Contact Person Email
- mponz@unav.es
- Site Name
- Institut Catala D'oncologia
- Department Name
- Oncology
- Principal Investigator Name
- Ramon Salazar
- Principal Investigator Email
- ramonsalazar@iconcologia.net
- Contact Person Name
- Ramon Salazar
- Contact Person Email
- ramonsalazar@iconcologia.net
- Site Name
- Complexo Hospitalario Universitario De Santiago
- Department Name
- Oncology
- Principal Investigator Name
- Elena Brozos
- Principal Investigator Email
- elenamaria.brozos.vazquez@sergas.es
- Contact Person Name
- Elena Brozos
- Contact Person Email
- elenamaria.brozos.vazquez@sergas.es
Sponsor
Primary sponsor
- Full Name
- Oncomatryx Biopharma S.A.
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- Spain
Related trials
Other published trials that may interest you.
- GDC-9545 for Locally advanced or metastatic estrogen receptor-positive breast cancer
- Abemaciclib for Stage IV lung cancer | Breast cancer
- BGB-43395 for Advanced or metastatic solid tumors | Hormone receptor positive HER2 negative breast cancer
- AZD9833 for Estrogen receptor-positive HER2-negative advanced breast cancer
- Pembrolizumab for Classical Hodgkin lymphoma | Melanoma | Solid tumours (MSI-H/dMMR) | Solid tumours (TMB-H)